Advances in the management of radiation-induced... (2023 study) Skip to main content
Clinical Guideline International journal of radiation biology 2023

Advances in the management of radiation-induced cystitis in patients with pelvic malignancies.

Wang Y, Zhu Y, Xu X, International journal of radiation biology, 2023

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors reviewed studies published from January 1990 to December 2021 on how radiation damage to the bladder (radiation cystitis) develops, how it can be prevented, and how it is managed.

What They Found

This review of studies on radiation cystitis in people treated with radiotherapy for pelvic tumors summarizes symptoms, grading scales, and the prevention and treatment options currently available. The abstract says high-dose radiation to the bladder wall is unavoidable in these treatments and leads to radiation cystitis. Symptoms include frequent urination, urgent urination, and nocturia, and in very severe cases the condition can be life-threatening. Treatment options listed are symptomatic treatment, vascular interventional therapy, surgery, hyperbaric oxygen therapy (HBOT), bladder irrigation, and electrocoagulation. Prevention options listed are filling the bladder to move it out of the radiation field, and delivering radiation with helical tomotherapy or CT-guided 3D intracavitary brachytherapy. The abstract gives no numbers on how well any option works.

What This Means for Canadian Patients

For people with radiation cystitis after pelvic radiotherapy, this review lists HBOT as one of several treatment options. The abstract does not say how well HBOT works, which patients it suits, or what pressure or number of sessions might be used. Patients should talk with their care team about which options fit their situation.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract describes a narrative review that only lists options and does not report outcome data, so it cannot show how effective HBOT or any other treatment is, or how the options compare.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Guideline
Category Radiation Injury
Source Pubmed
PubMed ID 36940182
Year Published 2023
Journal International journal of radiation biology
MeSH Terms Humans; Pelvic Neoplasms; Quality of Life; Cystitis; Radiation Injuries; Hyperbaric Oxygenation

Cite This Study

Share

This study relates to Delayed Radiation Injury. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology